Traditional Chinese medicine composition for treatment of type 2 diabetes

Abstract

The invention discloses a traditional Chinese medicine composition for treatment of type 2 diabetes, and the traditional Chinese medicine composition for treatment of type 2 diabetes is characterized by prepared from the following raw materials by weight: 1-20 parts of mulberry, 1-12 parts of poria, 1-9 parts of Hangzhou White Chrysanthemum, 1-11 parts of kudzu root, 1-15 parts of medlar, 1-8 parts of polygonatum odoratum, 1-12 parts of hawthorn, 1-9 parts of yam, 1-20 parts of propolis and 1-25 parts of bitter gourd. The traditional Chinese medicine composition is reasonable in compatibility, simple in medication, and exact in curative effect, can treat both symptoms and root causes, after packing by modern technology, the traditional Chinese medicine composition can be convenient for patients to take in time, and at the same time in the course of treatment, secondary failure and serious harmful response do not appear.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating type 2 diabetes. Background technique [0002] Type 2 diabetes mellitus (T2DM) is an endocrine and metabolic disease characterized by increased plasma glucose levels. Its pathophysiology is a metabolic disorder caused by insufficient relative insulin secretion or increased glucagon activity, which often leads to acid-base balance disorders in severe cases. , characterized by hyperglycemia, urine sugar, impaired glucose tolerance, and abnormal insulin release test. Sustained high blood sugar levels can cause a variety of complications, such as: hypertension, myocardial infarction, renal failure, retinopathy, and peripheral nervous system lesions, which can seriously endanger the quality of life and even life safety of patients. [0003] At present, Western medicine generally believes that insulin resistance and B...

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine generally believes that insulin resistance and B cell secretion defects are the two main links in the pathogenesis of T2DM. In terms of drug treatment, oral hypoglycemic drugs are mainly used. This method is relatively ideal for the initial control of blood sugar, but as the course of the disease progresses It is not uncommon for the secondary failure of oral hypoglycemic drugs to lead to poor blood sugar control. In order to further control blood sugar, the dosage of drugs is generally increased or the method of combining drugs is used, which is likely to increase the risk of adverse drug reactions, such as Hypoglycemia, gastrointestinal discomfort, liver function damage and other symptoms